Zobrazeno 1 - 5 of 5 pro vyhledávání: '"Vincent, Malquarti"'
1
Clinical Outcomes in Patients Treated With Biodegradable-Polymer Biolimus-Eluting Stents and 6 Months of Dual-Antiplatelet Therapy: The French eBiomatrix 6-Month DAPT Registry
Autor: Janusz, Lipiecki, Rajiv, Rampat, Christophe, Piot, Hakim, Benamer, François, Brunelle, Thierry, Lefèvre, Rami, El Mahmoud, Olivier, Varenne, Antoine, Gommeaux, Vincent, Malquarti, Denis, Angoulvant, Clauset, Cruchon, Keith, Oldroyd, Christian, Spaulding
Publikováno v: The Journal of invasive cardiology. 34(5)
Dual-antiplatelet treatment (DAPT) has conventionally been prescribed for 1 year after percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation. Recent evidence suggests that a duration of only 6 months may be equally safe
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::22d01ea0bf8a8e0aa05f77ba5608f39d
https://pubmed.ncbi.nlm.nih.gov/35451995
Zobrazit plný text záznamu
2
Cyclosporine before PCI in Patients with Acute Myocardial Infarction
Autor: Marc Metge, Gérald Vanzetto, David Garcia-Dorado, Martine Gilard, Philippe Dubois, Fabrice Prunier, Frédéric Moulin, Thierry Unterseeh, Gilles Grollier, Marie-Claude Morice, Arnaud Sudre, Philippe Gabriel Steg, Pierre Coste, Nathan Mewton, Thien-Tri Cung, P. Staat, Fabien de Poli, Marc J. Claeys, Meier Elbaz, Inesse Boussaha, Hervé Le Breton, Jean-Luc Dubois-Randé, Cyrille Bergerot, Patrice Guerin, Pascal Motreff, Guillaume Cayla, Denis Angoulvant, Olivier Roth, Nicolas Delarche, Michel Ovize, Christophe Piot, Grégoire Rangé, Jean-François Aupetit, Magnus Hansson, Eric Bonnefoy-Cudraz, Yves Cottin, P Coussement, Paul Barragan, Thierry Beard, Loic Belle, Olivier Morel, Vincent Malquarti, Didier Blanchard, Christophe Tron, Geneviève Derumeaux, Patrice Colin, Bernard Jouve, Omar Ider, Jean-Noël Labèque, Jérôme Clerc, Eskil Elmér, Claire Jossan, Gilles Rioufol
Publikováno v: New England Journal of Medicine
New England Journal of Medicine, 2015, 373 (11), pp.1021--1031. ⟨10.1056/NEJMoa1505489⟩
New England Journal of Medicine, Massachusetts Medical Society, 2015, 373 (11), pp.1021--1031. ⟨10.1056/NEJMoa1505489⟩
New England Journal of Medicine, 2015, 373 (11), pp.1021--1031. 〈10.1056/NEJMoa1505489〉
The New England journal of medicine
International audience; BACKGROUND: Experimental and clinical evidence suggests that cyclosporine may attenuate reperfusion injury and reduce myocardial infarct size. We aimed to test whether cyclosporine would improve clinical outcomes and prevent a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c896e8f5f0a4cc80fe11fb9ecb0f20e0
https://doi.org/10.1056/nejmoa1505489
Zobrazit plný text záznamu
3
Effect and safety of morphine use in acute anterior ST-segment elevation myocardial infarction
Autor: Mickael Bonin, Nathan Mewton, Francois Roubille, Olivier Morel, Guillaume Cayla, Denis Angoulvant, Meyer Elbaz, Marc J. Claeys, David Garcia‐Dorado, Céline Giraud, Gilles Rioufol, Claire Jossan, Michel Ovize, Patrice Guerin, Eric Bonnefoy‐Cudraz, Nicolas Delarche, Pierre Coste, Gerald Vanzetto, Marc Metge, Jean‐François Aupetit, Bernard Jouve, Pascal Motreff, Christophe Tron, Jean‐Noel Labeque, Philippe Gabriel Steg, Yves Cottin, Grégoire Range, Jérome Clerc, Patrick Coussement, Fabrice Prunier, Frédéric Moulin, Olivier Roth, Loïc Belle, Philippe Dubois, Paul Barragan, Martine Gilard, Christophe Piot, Patrice Colin, Fabien De Poli, Marie‐Claude Morice, Omar Ider, Jean‐Luc Dubois‐Randé, Thierry Unterseeh, Hervé Le Breton, Thierry Béard, Didier Blanchard, Gilles Grollier, Vincent Malquarti, Patrick Staat, Arnaud Sudre, Eskil Elmer, Magnus J. Hansson, Cyrille Bergerot, Inesse Boussaha, Geneviève Derumeaux
Publikováno v: Journal of the American Heart Association : Cardiovascular and cerebrovascular disease
Journal of the American Heart Association
Journal of the American Heart Association, Wiley-Blackwell, 2018, 7 (4), pp.e006833. ⟨10.1161/JAHA.117.006833⟩
Journal of the American Heart Association, 2018, 7 (4), pp.e006833. ⟨10.1161/JAHA.117.006833⟩
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Morphine is commonly used to treat chest pain during myocardial infarction, but its effect on cardiovascular outcome has never been directly evaluated. The aim of this study was to examine the effect and safety of morphine in patients with
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fab32d32c37c19ddc2989a59287e13c
https://hdl.handle.net/10067/1499140151162165141
Zobrazit plný text záznamu
4
Rationale and design of the Cyclosporine to ImpRove Clinical oUtcome in ST-elevation myocardial infarction patients (the CIRCUS trial)
Autor: David Garcia-Dorado, Frederique Moulin, Meyer Elbaz, Omar Ider, Martine Gilard, Claire Jossan, Gérald Vanzetto, Loic Belle, Pierre Coste, Patrice Colin, Thierry Unterseeh, Jean Luc Dubois-Rande, P. Staat, Gilles Grollier, Jean-Noël Labèque, Grégoire Rangé, P Coussement, Jérôme Clerc, Marc Metge, Jean-Pierre Monassier, Patrice Guerin, Didier Blanchard, Gilles Rioufol, Michel Ovize, Fabrice Prunier, Paul Barragan, Jean-François Aupetit, Eric Bonnefoy-Cudraz, Hervé Lebreton, Arnaud Sudre, Olivier Morel, Vincent Malquarti, Anna Torner, Eskil Elmér, Inesse Boussaha, Thierry Beard, Christophe Tron, Pascal Motreff, Yves Cottin, Guillaume Cayla, Christophe Piot, Olivier Roth, Bernard Jouve, Nicolas Delarche, Thien Tri Cung, P.G. Steg, Denis Angoulvant, Phillipe Dubois, Marie-Claude Morice, Magnus Hansson, Nathan Mewton, Marc J. Claeys
Publikováno v: American Heart Journal
American Heart Journal, 2015, 169 (6), pp.758--766.e6. ⟨10.1016/j.ahj.2015.02.020⟩
American Heart Journal, Elsevier, 2015, 169 (6), pp.758--766.e6. 〈10.1016/j.ahj.2015.02.020〉
American Heart Journal, Elsevier, 2015, 169 (6), pp.758--766.e6. ⟨10.1016/j.ahj.2015.02.020⟩
American heart journal
International audience; BACKGROUND: Both acute myocardial ischemia and reperfusion contribute to cardiomyocyte death in ST-elevation myocardial infarction (STEMI). The final infarct size is the principal determinant of subsequent clinical outcome in
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a7ba2978ce15e5d8737068574e7d08f
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01260554
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje